X
XLO
Xilio Therapeutics, Inc.
8.40
-0.06-0.71%Opening12:35 06/01 EDT
OPEN/PREV CLOSE8.47/8.46
TODAY RANGE8.20-8.49
VOL10.40K
MARKET CAP50.26M
52 WEEK RANGE6.47-16.10
AVG VOL (3M)48.49K
% TURNOVER0.17%
TURNOVER--
P/E (TTM)-2.3922
% RANGE3.43%
EPS(TTM)-3.5114
P/E(FORWARD)-2.7815
P/B0.6696
BVPS12.55
DIVIDEND--
P/S0.8696
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP32.34M
SHARES OUTSTANDING5.98M
NEXT EARNINGS08/14-08/20
FREE FLOAT3.85M
LOT SIZE1
EX-DATE03/16/2026
News
Press Releases
Financial Reports
Profile
NASDAQ·05/18 16:00
Cancer Stocks That Are Advancing the Future of Oncology Care
Seeking Alpha·05/12 16:53
Xilio Therapeutics reports Q1 results
TipRanks·05/12 16:42
Xilio Therapeutics files $250M mixed securities shelf
Reuters·05/12 11:49
XILIO THERAPEUTICS INC - MAY OFFER UP TO $250 MLN IN SECURITIES - SEC FILING
Dow Jones·05/12 11:33
*Xilio Therapeutics: Cash Runway Into Early 2028 >XLO
TipRanks·04/17 20:20
Xilio announces new preclinical data for XTX601 at AACR
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.